AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31

Authors: BAKER GA CAMFIELD C CAMFIELD P CRAMER JA ELGER CE JOHNSON AL DASILVA AM MEINARDI H MUNARI C PERUCCA E THORBECKE R
Citation: Ga. Baker et al., COMMISSION ON OUTCOME MEASUREMENT IN EPILEPSY, 1994-1997 - FINAL REPORT, Epilepsia, 39(2), 1998, pp. 213-231

Authors: TRENITE DGAKN MEINARDI H HEKSTER YA
Citation: Dgakn. Trenite et al., AED-EFFICACY AND OUTCOME MEASUREMENTS FOR EFFECTIVENESS - EVALUATION OF ANTIEPILEPTIC DRUGS IN THE DIFFERENT PHASES OF DEVELOPMENT, Pharmacy world & science, 19(5), 1997, pp. 213-213

Authors: DECKERS CLP HEKSTER YA KEYSER A MEINARDI H RENIER WO
Citation: Clp. Deckers et al., PHARMACOTHERAPY OF EPILEPSY - STATE-OF-THE-ART AND DEVELOPMENTS, Journal of clinical pharmacy and therapeutics, 22(5-6), 1997, pp. 309-322

Authors: NATSCH S HEKSTER YA KEYSER A DECKERS CLP MEINARDI H RENIER WO
Citation: S. Natsch et al., NEWER ANTICONVULSANT DRUGS - ROLE OF PHARMACOLOGY, DRUG-INTERACTIONS AND ADVERSE REACTIONS IN DRUG CHOICE, Drug safety, 17(4), 1997, pp. 228-240

Authors: SAMREN EB VANDUIJN CM KOCH S HIILESMAA VK KLEPEL H BARDY AH MANNAGETTA GB DEICHL AW GAILY E GRANSTROM ML MEINARDI H GROBBEE DE HOFMAN A JANZ D LINDHOUT D
Citation: Eb. Samren et al., MATERNAL USE OF ANTIEPILEPTIC DRUGS AND THE RISK OF MAJOR CONGENITAL-MALFORMATIONS - A JOINT EUROPEAN PROSPECTIVE-STUDY OF HUMAN TERATOGENESIS ASSOCIATED WITH MATERNAL EPILEPSY, Epilepsia, 38(9), 1997, pp. 981-990

Authors: DECKERS CLP HEKSTER YA KEYSER A MEINARDI H RENIER WO
Citation: Clp. Deckers et al., REAPPRAISAL OF POLYTHERAPY IN EPILEPSY - A CRITICAL-REVIEW OF DRUG LOAD AND ADVERSE-EFFECTS, Epilepsia, 38(5), 1997, pp. 570-575

Authors: LI XH BRETELER MMB DEBRUYNE MC MEINARDI H HAUSER WA HOFMAN A
Citation: Xh. Li et al., VASCULAR DETERMINANTS OF EPILEPSY - THE ROTTERDAM STUDY, Epilepsia, 38(11), 1997, pp. 1216-1220

Authors: DECKERS CLP HEKSTER YA KEYSER A MEINARDI H RENIER WO
Citation: Clp. Deckers et al., DRUG LOAD IN CLINICAL-TRIALS - A NEGLECTED FACTOR, Clinical pharmacology and therapeutics, 62(6), 1997, pp. 592-595

Authors: DECKERS CLP HEKSTER YA KEYSER A LAMMERS MW MEINARDI H RENIER WO
Citation: Clp. Deckers et al., ADVERSE-EFFECTS IN EPILEPSY THERAPY - WAIT AND SEE OR GO FOR IT, Acta neurologica Scandinavica, 95(4), 1997, pp. 248-252

Authors: LAMMERS MW HEKSTER YA KEYSER A MEINARDI H RENIER WO HERINGS RMC
Citation: Mw. Lammers et al., USE OF ANTIEPILEPTIC DRUGS IN A COMMUNITY-DWELLING DUTCH POPULATION, Neurology, 46(1), 1996, pp. 62-67

Authors: SCHOLTES FB RENIER WO MEINARDI H
Citation: Fb. Scholtes et al., SIMPLE PARTIAL STATUS EPILEPTICUS - CAUSES, TREATMENT, AND OUTCOME IN47 PATIENTS, Journal of Neurology, Neurosurgery and Psychiatry, 61(1), 1996, pp. 90-92

Authors: SCHOLTES FB RENIER WO MEINARDI H
Citation: Fb. Scholtes et al., NONCONVULSIVE STATUS EPILEPTICUS - CAUSES, TREATMENT, AND OUTCOME IN 65 PATIENTS, Journal of Neurology, Neurosurgery and Psychiatry, 61(1), 1996, pp. 93-95

Authors: DELACOURT A BRETELER MMB MEINARDI H HAUSER WA HOFMAN A
Citation: A. Delacourt et al., PREVALENCE OF EPILEPSY IN THE ELDERLY - THE ROTTERDAM STUDY, Epilepsia, 37(2), 1996, pp. 141-147

Authors: DEBITTENCOURT PRM ADAMOLEKUM B BHARUCHA N CARPIO A COSSIO OH DANESI MA DUMAS M MEINARDI H ORDINARIO A SENANAYAKE N SHAKIR R
Citation: Prm. Debittencourt et al., EPILEPSY IN THE TROPICS .1. EPIDEMIOLOGY, SOCIOECONOMIC RISK-FACTORS,AND ETIOLOGY, Epilepsia, 37(11), 1996, pp. 1121-1127

Authors: DEBITTENCOURT PRM ADAMOLEKUM B BHARUCHA N CARPIO A COSSIO OH DANESI MA DUMAS M FERNANDES JG GENTON P MANREZA ML MEINARDI H ORDINARIO A SENANAYAKE N SHAKIR R SINGHAL BS SOTELO J
Citation: Prm. Debittencourt et al., EPILEPSY IN THE TROPICS .2. CLINICAL PRESENTATIONS, PATHOPHYSIOLOGY, IMMUNOLOGICAL DIAGNOSIS, ECONOMICS, AND THERAPY, Epilepsia, 37(11), 1996, pp. 1128-1137

Authors: LAMMERS MW HEKSTER YA KEYSER A VANLIER H MEINARDI H RENIER WO
Citation: Mw. Lammers et al., NEITHER DOSAGE NOR SERUM LEVELS OF ANTIEPILEPTIC DRUGS ARE PREDICTIVEFOR EFFICACY AND ADVERSE-EFFECTS, Pharmacy world & science, 17(6), 1995, pp. 201-206

Authors: LAMMERS MW HEKSTER YA KEYSER A MEINARDI H RENIER WO VANLIER H
Citation: Mw. Lammers et al., MONOTHERAPY OR POLYTHERAPY FOR EPILEPSY REVISITED - A QUANTITATIVE ASSESSMENT, Epilepsia, 36(5), 1995, pp. 440-446

Authors: LAMMERS MW HEKSTER YA KEYSER A VANLIER H MEINARDI H RENIER WO
Citation: Mw. Lammers et al., MONOTHERAPY OR POLYTHERAPY FOR EPILEPSY REVISITED, Epilepsia, 36, 1995, pp. 59-59

Authors: TIMMERS L VANMEER JH WOLSCHRIJN H MEINARDI H
Citation: L. Timmers et al., A SOLUTION FOR EPILEPSY TREATMENT IN RURAL-AREAS, Epilepsia, 36, 1995, pp. 74-74

Authors: MEINARDI H
Citation: H. Meinardi, THE OUTCOME OF EPILEPSY AND ITS MEASUREMENT, Epilepsia, 36, 1995, pp. 36-40

Authors: VANENGELEN BGM RENIER WO WEEMAES CMR GABREELS FJM MEINARDI H
Citation: Bgm. Vanengelen et al., IMMUNOGLOBULIN TREATMENT IN EPILEPSY, A REVIEW OF THE LITERATURE, Epilepsy research, 19(3), 1994, pp. 181-190

Authors: VANPARYS JAP MEINARDI H
Citation: Jap. Vanparys et H. Meinardi, SURVEY OF 260 EPILEPTIC PATIENTS TREATED WITH OXCARBAZEPINE (TRILEPTAL(R)) ON A NAMED-PATIENT BASIS, Epilepsy research, 19(1), 1994, pp. 79-85

Authors: VANENGELEN BGM RENIER WO WEEMAES CMR LAMERS KJB GABREELS FJM MEINARDI H
Citation: Bgm. Vanengelen et al., CEREBROSPINAL-FLUID EXAMINATIONS IN CRYPTOGENIC WEST AND LENNOX-GASTAUT SYNDROME BEFORE AND AFTER INTRAVENOUS IMMUNOGLOBULIN ADMINISTRATION, Epilepsy research, 18(2), 1994, pp. 139-147

Authors: MEINARDI H
Citation: H. Meinardi, EPICADEC QUO-VADIS, Tropical and geographical medicine, 46(3), 1994, pp. 190000003-190000003

Authors: MEINARDI H
Citation: H. Meinardi, GENERAL DESCRIPTION OF PROJECTS SUPPORTED BY EPICADEC .1., Tropical and geographical medicine, 46(3), 1994, pp. 190000004-190000005
Risultati: 1-25 | 26-31